Product Images Imatinib Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Imatinib Mesylate NDC 64679-794 by Wockhardt Usa Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a statistical table showing data related to treatment with Imatinib Mesylate Tablets and IFNsAraC in patients without progression. The table shows the number of patients with progression or censored at discontinuation or last follow-up, Hazard Ratio, and Logrank Test P-value. The data is presented for several months since randomization.*
This appears to be a statistical table that shows the effectiveness of Imatinib Mesylate tablets compared to IFN + Ara-C in treating patients with progression to AP or BC. The table shows the number of patients and events (censored at discontinuation or last follow-up) in each arm, along with a hazard ratio and Logrank test results. The table is organized by months since randomization.*
Each film-coated tablet contains 100 mg of imatinib free base. This medicine should be stored at a temperature of 25°C (77°F), with excursions permitted to 15°-30°C (59°-86°F). It should be kept in a dry container, protected from moisture. The manufacturer of this medicine is Shipa Medicar, and it was distributed by WeekhardtUSA LLC. The drug is available in 30 tablets, and the usual dosage is indicated in the package insert. It is important to keep this drug and all others out of the reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.